natgillin/translations-raw huggingface dataset:
Mild and transient neurological disorders such as ataxia or tremor may occur in very rare cases.
Zelo redko se lahko pojavijo lažje in prehodne nevrološke motnje, kot so nekoordiniranost gibov in mišično drgetanje.
Mild and transient oedema was observed early during the course of treatment with somatropin.
V zgodnji fazi zdravljenja s somatropinom so opazili blag in prehoden edem.
Mild and transient side effects affecting the gut that occurred rarely (affecting more than 1 but less than 10 animals in 10,000 animals) were (in order of decreasing frequency) mild and intermittent regurgitation, vomiting, diarrhoea or soft faeces.
Redki blagi in prehodni neželeni učinki v črevesju (pojavili so se pri več kot eni, a manj kot 10 mačkah od 10 000), so bili (po padajoči pogostnosti):blagi in občasni refluks kisline, bruhanje, diareja ali mehko blato.
Mild and transient signs may be observed with spontaneous recovery the day after – see description in section 6.
Pojavili so se lahko blagi in prehodni, ki so spontano prenehali naslednji dan – glejte opis v poglavju 6.
Mild and transient skin reactions at the application site (itching, hair loss) may occur and disappear without treatment.
Na mestu nanosa se lahko pojavijo blage in prehodne reakcije na koži (srbečica, izpadanje dlake).
Mild and transient skin reactions at the application site (itching, hair loss) may occur.
Na mestu nanosa se lahko pojavijo blage in prehodne reakcije na koži (srbečica, izpadanje dlake).
Mild b
Blagab
mild blood sugar increase
blago povečanje krvnega sladkorja
Mild breast symptoms such as pain, enlargement and tenderness
Blagi simptomi dojk kot so bolečina, povečanje in občutljivost
Mild CYP3A4 inhibitors
Šibki zaviralci CYP3A4
Mild diarrhoea, constipation and stomach pain
blaga driska, zaprtje in bolečine v trebuhu
Mild elevations of an enzyme called ALT (alanine aminotransferase) occurred in all dogs treated with Comfortis, although values returned to their baseline by day 24.
Pri vseh psih, zdravljenih z zdravilom Comfortis, je prišlo do blagega dviga ALT (alanin aminotransferaze), čeprav so se vrednosti ALT vrnile na izhodiščne do 24. dne.
Mild erythematous lesions have been observed.
Pojavi se lahko blaga rdečina.
Mild flaking of skin associated with dryness, rash and acne
blaga luskavost kože, povezana s suho kožo, osipom in aknami
Mild gastrointestinal effects (vomiting, diarrhoea), pruritus, lethargy, or anorexia may be observed on very rare occasions.
V zelo redkih primerih se lahko pojavijo blagi gastrointestinalni učinki (bruhanje, driska), pruritus, letargija ali anoreksija.
Mild gastrointestinal effects (vomiting, diarrhoea), pruritus, lethargy, or anorexia may be observed on very rare* occasions.
V zelo redkih* primerih se lahko pojavijo blagi gastrointestinalni učinki (bruhanje, driska), pruritus, letargija ali anoreksija.
Mild GFR = 50-80 ml/min; Moderate GFR = 30-50 ml/min; Severe GFR = <30 ml/min
Blaga okvara: GFR = 50-80 ml/min; Zmerna: GFR = 30-50 ml/min; Huda: GFR = < 30 ml/min
Mild hepatic impairment
Blaga jetrna okvara
Mild hepatic impairment (see sections 4.2 and 5.2).
Blaga jetrna okvara (glejte poglavji 4.2 in 5.2).
Mild HI
Blaga OJ
Mild hypoglycaemic episodes can be treated by oral administration of glucose or other products containing sugar.
Blage epizode hipoglikemije je mogoče zdraviti z zaužitjem glukoze ali drugih izdelkov, ki vsebujejo sladkor.
Mild hypoglycaemic episodes can be treated by oral administration of glucose or other products containing sugar.
Blage hipoglikemije se lahko zdravi z zaužitjem glukoze ali živil, ki vsebujejo sladkor.
Mild hypoglycaemic episodes can be treated by oral administration of glucose or sugary products.
Blage hipoglikemije je mogoce zdraviti z zaužitjem glukoze ali sladkih izdelkov.
Mild hypoglycaemic episodes can be treated by oral administration of glucose or sugary products.
Blage hipoglikemije se lahko zdravi z zaužitjem glukoze ali sladkih živil.
mild hypotension (mildly reduced blood pressure, which may make you feel faint upon standing)
blaga hipotenzija (blago znižanje krvnega tlaka, zaradi česar se vam lahko vrti, kadar stojite)
mild hypotension (mildly reduced blood pressure, which may make you feel faint upon standing)
blaga hipotenzija (blago znižanje krvnega tlaka, zaradi česar se vam lahko vrti, ko vstanete)
mild hypotension (mildly reduced blood pressure, which may make you feel faint upon standing) nausea
blaga hipotenzija (blago znižanje krvnega tlaka, zaradi česar se vam lahko vrti, kadar vstanete) občutek siljenja na bruhanje
mild hypotension (mildly reduced blood pressure, which may make you feel faint upon standing) nausea
blaga hipotenzija (blago znižanje krvnega tlaka, zaradi česar se vam lahko vrti, ko vstanete) občutek siljenja na bruhanje
mild increase in blood pressure,
blago zvišanje krvnega tlaka,
Mild increase in blood pressure.
blago zvišanje krvnega tlaka,
Mild increase of blood sugar levels (mild hyperglycaemia) (1% in children; 1% - 10% in adults)
blago zvišanje ravni sladkorja v krvi (blaga hiperglikemija) (1 % pri otrocih; 1 % - 10 % pri odraslih)
Mild increases in concentrations of
Pričakovati je mogoče blago
Mild increases in simeprevir concentrations may
tadalafilom v odmerkih, ki
Mild increases in simeprevir concentrations may occur due to inhibition of CYP3A4 by amiodarone.
pričakovati blago zvečanje koncentracije
Mild increases in transaminase, ALT below or equal to 3-fold ULN were more frequently seen in teriflunomide-treated groups as compared to placebo.
Blago zvišanje ravni transaminaz, ALT nižji ali enak 3-kratniku zgornje meje normalnih vrednosti (ULN – Upper limit of Normal), so pogosteje ugotovili pri bolnikih, ki so prejemali teriflunomid, kot pri bolnikih, ki so prejemali placebo.
Mild injection site swellings associated with perivascular inflammation and pain.
Blage reakcije v obliki otekline in perivaskularnega vnetja in bolečina.
Mild injection site thrombosis has been observed at higher doses.
Pri uporabi večjih odmerkov so poročali o pojavu blage tromboze na mestu injiciranja.
Mild irritancy of the nasal cavity and larynx were seen in rodents.
Pri glodalcih so opažali blago draženje sluznice v nosni votlini in grlu.
Mild irritancy of the nasal cavity and larynx were seen in rodents.
Pri glodalcih so opažali blago draženje v nosni votlini in grlu.
Mild irritation in the throat, coughing, hoarseness
blago draženje grla, kašljanje, hripavost
mild lethargy and drowsiness
blaga letargija in somnolenca
Mild loss of hair
rahlo izpadanje las
Mild opioid-withdrawal-like symptoms (any of the following: feeling cold, shivering, runny nose, sweating, hair standing on end, blushing, fast heart beat)
blagi simptomi, podobni odtegnitvenim pri opioidih (kar koli od naslednjega: občutek mrazenja, tresenje, nahod, znojenje, kurja polt, oblivanje, hitro utripanje srca)
Mild or moderate IRRs (section 4.8) usually respond to a reduction in the rate of infusion.
Blage ali zmerne reakcije, povezane z infuzijo (poglavje 4.8), lahko običajno zmanjšamo z manjšim infuzijskim pretokom.
Mild or moderate OHSS is common, while severe OHSS is uncommon.
Blage ali zmerne oblike tega sindroma so dokaj pogoste, hude oblike pa so redke.
Mild or moderate renal impairment (creatinine clearance 30 to 80 ml/min):
Blaga ali zmerna okvara ledvic (očistek kreatinina od 30 do 80 ml/min):
Mild or moderate severity headache was reported in 5.8% of patients.
O blagem ali zmernem glavobolu so poročali pri 5,8 % bolnic.
Mild pain and inflammation at the site of injection due to accidental administration of the medicinal product into the surrounding tissue (extravasation) e.g. by leakage.
Blage bolečine in vnetje na mestu injiciranja zaradi naključnega prehajanja zdravila v okoliško tkivo (ekstravazacija), npr. zaradi iztekanja.
Mild peripheral neuropathy
blaga periferna nevropatija
Mild rashes e.g. with hives or with flat or raised small red spots
blag izpuščaj, npr. s koprivnico ali ploskimi ali privzdignjenimi rdečimi lisami,
Mild rectal bleeding (see section 4.4)
divertikulitis pankreatitis blaga krvavitev v predelu danke (glejte poglavje 4.4)
Mild reduction in blood platelets, which increases the risk of bleeding or bruising.
blago zmanjšanje števila krvnih ploščic, kar poveča tveganje za krvavitve in nastanek modric
Mild renal impairment (60-89 ml/min)
Blaga ledvična okvara (60 -89 ml/min)
Mild renal impairment (CrCl 50-80 mL/min)
Blaga ledvična okvara (CrCl 50–80 ml/min)
Mild renal impairment (CrCl 51 to 80 ml/min)
Blaga ledvična okvara (CrCl 51 do 80 ml/min)
Mild renal impairment (CrCl 60 to 89 mL/min) or moderate renal impairment (CrCl 30 to 59 mL/min)
Blaga ledvična okvara (očistek kreatinina od 60 do 89 ml/min) ali zmerna ledvična okvara (očistek kreatinina od 30 do 59 ml/min)
Mild renal impairment (creatinine clearance 50-80 ml/min)
Blaga ledvična okvara (očistek kreatinina 50-80 ml/min)
Mild sedation (sleepiness) for up to 24 hours after Recuvyra has been applied by your veterinarian.
Blago sedacijo (zaspanost) do 24 ur potem, ko je veterinar nanesel Recuvyro.
Mild skin
fisure na koži
Mild sore throat, coughing and a hoarse voice.
blago vnetje žrela, kašelj in hripavost,
Mild swellings or nodules up to 3 cm diameter were observed at the injection site after administration of a 10-fold overdose and disappeared within 4 days post vaccination.
Po dajanju desetkrat prevelikega odmerka so na mestu injiciranja opazili blage otekline ali vozliče do 3 cm v premeru, ki so izginili v 4 dneh po cepljenju.
Mild swellings or nodules up to 3 cm diameter were observed at the injection site and disappeared within 4 days post vaccination.
Na mestu injiciranja so opazili blage otekline ali vozliče, ki so imeli do 3 cm v premeru in so izginili v 4 dneh po cepljenju.
Mild systemic reactions may uncommonly be observed up to one day after vaccination and consist of being less active, a tendency of the animal to lie down and minor signs of discomfort.
Blage sistemske reakcije se lahko občasno pojavijo do en dan po cepljenju in se kažejo v manjši aktivnosti živali, s tendenco, da bi se ulegle, in z manjšimi znaki nelagodja.
Mild systemic reactions may uncommonly be observed up to one day of vaccination and consist of being less active, a tendency of the animal to lie down and minor signs of discomfort.
Blage sistemske reakcije se lahko pojavijo do en dan po cepljenju in se kažejo v manjši aktivnosti živali, s tendenco, da bi se ulegle, in z manjšimi znaki nelagodja.
Mild to moderate
Blagi do zmerni
Mild to moderate adverse reactions
Blagi do zmerni neželeni učinki
Mild to moderate bleeding episodes (including home therapy)
Blage do zmerne krvavitve (vključno z zdravljenjem na domu)
Mild to moderate degrees of hepatic impairment (Child-Pugh class B) (see section 5.2) did not result in a relevant change in pharmacokinetics of telavancin.
Blage do zmerne stopnje okvare jeter (Child–Pugh razred B) (glejte poglavje 5.2) niso pomembno spremenile farmakokinetike telavancina.
Mild to moderate rash, including:
O blagem do zmernem izpuščaju, ki vključuje:
Mild to moderate rashes including urticarial rash, maculopapular rash, and photosensitivity have been reported in subjects receiving Aptivus, co-administered with low dose ritonavir.
Pri bolnikih, ki so prejemali zdravilo Aptivus, ob hkratnih majhnih odmerkih ritonavirja, so poročali o blagem do zmernem izpuščaju v obliki urtikarije in makulopapularnega izpuščaja ter o fotosenzibilnosti.
mild to moderate reduction in all blood cell counts
blago do zmerno zmanjšanje števila vseh vrst krvničk,
Mild to moderate renal impairment (creatinine clearance 30–80 ml/min) (see sections 4.2, 4.8, and 5.2).
Blaga do zmerna ledvična okvara (kreatininski očistek 30–80 ml/min) (glejte poglavja 4.2, 4.8 in 5.2).
Mild to moderate skin reactions can be managed by symptomatic treatment, or by dose reduction or interruption.
Blage do zmerne kožne reakcije je mogoče obvladati s simptomatskim zdravljenjem in/ali s prilagoditvijo odmerka.
Mild to severe hypersensitivity reactions, including anaphylactic reactions and shock
blage do hude preobčutljivostne reakcije, vključno z anafilaktičnimi reakcijami in šokom
mild to severe nausea, vomiting, cramps and diarrhoea, usually caused by a virus, stomach pain
blaga do huda slabost v želodcu, bruhanje, krči in driska (po navadi so vzrok virusi), bolečine v trebuhu
mild tremor (shaking) of the fingers pseudocysts of the pancreas (collections of fluid after acute inflammation of the pancreas)
blag tremor (tresenje) prstov rok, psevdociste pankreasa (zbiri tekočine po akutnem vnetju trebušne slinavke).
Mild twitching of the fingers;
blago trzanje prstov,
Mild w/o ecchymosis, oozing and haematoma <5 cm
Blaga brez ekhimoze, izcejanja in hematoma < 5 cm
Mild, indirect (unconjugated) hyperbilirubinaemia may occur in patients with Gilbert’s syndrome.
Bolnikom z Gilbertovim sindromom se lahko pojavi blaga indirektna (nekonjugirana) hiperbilirubinemija.
Mild, indirect (unconjugated) hyperbilirubinaemia may occur in patients with Gilbert’s syndrome.
Pri bolnikih z Gilbertovim sindromom se lahko pojavi blaga, indirektna (nekonjugirana) hiperbilirubinemija.
Mild, transient anticholinergi c effects including constipation and dry mouth
blagi prehodni antiholinergični učinki, vključno z zaprtjem in suhimi usti
Mild, transient anticholinergic
Blagi prehodni antiholinergični
Mild, transient anticholinergic effects
Blagi prehodni antiholinergični učinki, vključno z zaprtjem in suhimi usti
Mild, transient anticholinergic effects including
Blagi prehodni antiholinergični učinki, vključno z zaprtjem in suhimi usti
Mild, transient anticholinergic effects including constipation and dry mouth
blagi prehodni antiholinergičn i učinki, vključno z zaprtjem in suhimi usti
Mild, transient anticholinergic effects including constipation and dry mouth
Blagi prehodni antiholinergični
Mild, transient anticholinergic effects including constipation and dry mouth
Blagi prehodni antiholinergični učinki, vključno z zaprtjem in suhimi usti
Mild-moderate tachycardia (50%), hypertension (26%) and hypotension (29%) were very commonly reported in uncontrolled studies of mifamurtide.
V nenadzorovanih študijah mifamurtida so zelo pogosto poročali o blagi do zmerni tahikardiji (50 %), hipertenziji (26 %) in hipotenziji (29 %).
Mild-to-moderate rash has been reported with the individual components of Atripla.
Pri posameznih učinkovinah zdravila Atripla so poročali o blagem do zmernem izpuščaju.
Mild: GFR 60 to 89 mL/min/1.73 m2; moderate: GFR 30 to 59 mL/min/1.73 m2; severe: GFR 15 to 29 mL/min/1.73 m2.
Blaga: GFR 60 do 89 ml/min/1,73 m2; zmerna: GFR 30 do 59 ml/min/1,73 m2; huda: GFR 15 do 29 ml/min/1,73 m2.
Mildly anaemic patients (haematocrit of 33 to 39 %) requiring predeposit of  4 units of blood should be treated with Abseamed 600 IU/kg intravenously, 2 times per week for 3 weeks prior to surgery.
Blago anemične bolnike (hematokrit 33 do 39 %), ki potrebujejo  4 enote deponirane krvi, je treba zdraviti z zdravilom Abseamed 600 i.e./kg, intravensko, 2-krat na teden, 3 tedne pred kirurškim posegom.
Mildly anaemic patients (haematocrit of 33 to 39 %) requiring predeposit of  4 units of blood should be treated with Binocrit 600 IU/kg intravenously, 2 times per week for 3 weeks prior to surgery.
Blago anemične bolnike (hematokrit 33 do 39 %), ki potrebujejo  4 enote deponirane krvi, je treba zdraviti z zdravilom Binocrit 600 i.e./kg, intravensko, 2-krat na teden, 3 tedne pred kirurškim posegom.
Mildly anaemic patients (haematocrit of 33 to 39 %) requiring predeposit of  4 units of blood should be treated with Epoetin alfa HEXAL 600 IU/kg intravenously, 2 times per week for 3 weeks prior to surgery.
Blago anemične bolnike (hematokrit 33 do 39 %), ki potrebujejo  4 enote deponirane krvi, je treba zdraviti z zdravilom Epoetin alfa HEXAL 600 i.e./kg, intravensko, 2-krat na teden, 3 tedne pred kirurškim posegom.
Mildly anaemic patients (haematocrit of 33-39%) requiring predeposit of ≥ 4 units of blood should be treated with Retacrit at a dose of 600 IU/kg body weight 2 times weekly for 3 weeks prior to surgery.
Blago anemičnim bolnikom (hematokrit 33-39%), ki potrebujejo zalogo ≥ 4 enot krvi, je treba dajati zdravilo Retacrit v odmerku 600 i.e./kg telesne mase dvakrat tedensko, 3 tedne pred operacijo.
Mildly decreased trabecular and cortical bone was seen in female rats administered ≥ 100 mg/kg/day (AUC exposure margin of 20.3-fold).
Pri podganjih samicah, ki so jim dajali odmerke ≥ 100 mg/kg/dan (z mejo izpostavljenosti, ki je bila 20,3-kratnik AUC) so opazili nekoliko zmanjšan volumen trabekularne in kortikalne kostnine.
Milk can be taken immediately for both sheep and cattle.
Mleko ovc in krav se lahko uporabi takoj.
Milk excretion has not been measured in the animal studies, however a study in rats showed some effects on offspring development during lactation which are compatible with excretion of ritonavir in milk in that species.
V študijah na živalih niso merili izločanja v mleko, vendar je študija na podganah pri razvoju mladičev odkrila nekatere učinke, združljive z izločanjem ritonavirja v mleko te živalske vrste.
Milk excretion has not been measured in the animal studies, however a study in rats showed some effects on offspring development during lactation which are compatible with excretion of ritonavir in milk in that species.
V študijah na živalih niso merili izločanja v mleku, vendar je študija na podganah pri razvoju mladičev odkrila nekatere učinke, združljive z izločanjem ritonavirja v mleko te živalske vrste.
Milk levels of omalizumab were 0.15% of the maternal serum concentration.
Koncentracije omalizumaba v mleku so znašale 0,15 % koncentracije v materinem serumu.
Milk or antacids should be given to bind Ibandronic Acid Teva, and any adverse reactions treated symptomatically.
Za vezavo zdravila Ibandronska kislina Teva je treba zaužiti mleko ali antacide, neželeni učinki pa se zdravijo simptomatično.
milk or milk shakes, drinks containing milk, yoghurt or cream
mleka ali mlečnih napitkov, kot so pijače, ki vsebujejo mleko, jogurt ali smetano.
milk thistle (a herbal medicine)
pegasti badelj (zdravilo rastlinskega izvora)
Milk thistle (Silybum marianum)
pegasti badelj (Silybum marianum)
Milk: - zero hours after calving when the dry period length is 32 days or more.
Nič ur po telitvi, ko je obdobje presušitve 32 dni ali več.
Milk: 5 days (cattle)
5 dni (govedo)
Milk: 5 days (cattle)
Mleko: 5 dni (goveda)
Milk: 5 days Pigs and horses
prašiči in konji
Milk: Zero days
Mleko: nič dni
Milk: Zero days
Nič dni
Million International Units, measured by cytopathic effect (CPE) bioassay against the in-house interferon beta-1a standard which is calibrated against the current international NIH standard (GB-23-902-531).
milijon mednarodnih enot, merjeno z biološkim testom s citopatskim učinkom (CPE) po standardu proizvajalca za interferon beta-1a, ki je kalibriran po trenutnem mednarodnem NIH standardu (GB-23-902-531).
Million women study (Estradiol only arm) – estimated additional risk of breast cancer after 5 years use
Študija Million Women Study (skupina, ki je prejemala samo estradiol) – ocenjeno dodatno tveganje za raka dojke po 5 letih uporabe
Mimpara 30 mg film-coate d tablets Mimpara 60 mg film-coate d tablets Mimpara 90 mg film-coate d tablets Cinacalcet
Mimpara 30 mg filmsko oblože ne table te Mimpara 60 mg filmsko oblože ne table te Mimpara 90 mg filmsko oblože ne table te cinakalcet
Mimpara 30 mg film-coated tablets Cinacalcet
Mimpara 30 mg filmsko obložene tablete cinakalcet
Mimpara 30 mg film-coated tablets.
Mimpara 30 mg filmsko obložene tablete
Mimpara 30 mg tablet Cinacalcet
Mimpara 30 mg tableta cinakalcet
Mimpara 60 mg film-coated tablets Cinacalcet
Mimpara 60 mg filmsko obložene tablete cinakalcet
Mimpara 60 mg film-coated tablets.
Mimpara 60 mg filmsko obložene tablete
Mimpara 60 mg tablet Cinacalcet
Mimpara 60 mg tableta cinakalcet
Mimpara 90 mg film-coated tablets Cinacalcet
Mimpara 90 mg filmsko obložene tablete cinakalcet
Mimpara 90 mg film-coated tablets.
Mimpara 90 mg filmsko obložene tablete
Mimpara 90 mg tablet Cinacalcet
Mimpara 90 mg tableta cinakalcet
Mimpara brought about a 42% reduction in PTH levels compared with an increase of 8% in patients taking placebo.
Zdravilo Mimpara je zmanjšalo ravni paratiroidnega hormona za 42 % v primerjavi s povečanjem za 8 % pri bolnikih, ki so jemali placebo.
Mimpara has also been studied in a study involving 46 patients with hypercalcaemia, including 29 with parathyroid carcinoma, and 17 with primary hyperparathyroidism who could not have their parathyroid glands removed or in whom surgery to remove the parathyroid glands was not effective.
Zdravilo Mimpara so proučevali tudi v študiji, ki je vključevala 46 bolnikov s hiperkalciemijo, od tega 29 bolnikov s paratiroidnim karcinomom in 17 bolnikov s primarnim hiperparatiroidizmom, pri katerih obščitnic ni bilo mogoče odstraniti ali pri katerih kirurška odstranitev obščitnic ni bila učinkovita.
Mimpara has been compared with placebo (a dummy treatment) in three main studies involving 1,136 dialysis patients with serious kidney disease.
Zdravilo Mimpara so primerjali s placebom (zdravilom brez zdravilne učinkovine) v treh glavnih študijah, ki so vključevale 1 136 dializnih bolnikov s hudim obolenjem ledvic.
Mimpara is a light green film-coated tablet.
Zdravilo Mimpara je svetlo zelena, filmsko obložena tableta.
Mimpara is a medicine that contains the active substance cinacalcet.
Mimpara je zdravilo, ki vsebuje zdravilno učinkovino cinakalcet.
Mimpara is available in bottles of 30 mg, 60 mg or 90 mg film-coated tablets, inside a carton.
Mimpara je na voljo v steklenicah (30 mg, 60 mg ali 90 mg filmsko obložene tablete) v škatli.
Mimpara is not indicated for use in children and adolescents due to a lack of data on safety and efficacy (see section 4.4).
Zaradi pomanjkanja podatkov o varnosti in učinkovitosti zdravilo Mimpara ni indicirano za uporabo pri otrocih in mladostnikih (glejte poglavje 4.4).
Mimpara is not indicated for use in paediatric patients.
Zdravilo Mimpara ni indicirano za uporabo pri pediatričnih bolnikih.
Mimpara is taken with food or shortly after a meal.
Zdravilo Mimpara se jemlje s hrano ali kmalu po obroku.
Mimpara is used in adults and elderly patients in the following ways: to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products.
Zdravilo Mimpara se uporablja pri odraslih in starostnikih: za zdravljenje sekundarnega hiperparatiroidizma pri bolnikih z resnim ledvičnim obolenjem, ki za izločanje odpadnih snovi iz krvi potrebujejo dializo.
Mimpara is used:
Zdravilo Mimpara uporabljamo:
Mimpara produced a decrease in blood calcium of more than 1 mg/dl in 62% of the cancer patients (18 out of 29) and in 88% of the patients with primary hyperparathyroidism (15 out of 17).
Zdravilo Mimpara je privedlo do znižanja ravni kalcija v krvi za več kot 1 mg/dl pri 62 % bolnikov z rakom (pri 18 bolnikih od 29) in pri 88 % bolnikov s primarnim hiperparatiroidizmom (pri 15 bolnikih od 17).
Mimpara should be taken with or shortly after food.
Zdravilo Mimpara morate vzeti s hrano ali kmalu po jedi.
Mimpara should not be used in people who may be hypersensitive (allergic) to cinacalcet or any of the other ingredients.
Zdravila Mimpara ne smejo uporabljati osebe, ki utegnejo biti preobčutljive za (alergične na) cinakalcet ali katero koli drugo sestavino zdravila.
Mimpara treatment should not be initiated in patients with a serum calcium (corrected for albumin) below the lower limit of the normal range.
Zdravljenja z zdravilom Mimpara ne smete začeti pri bolnikih, ki imajo kalcij v serumu (korigiran za albumin) pod spodnjo mejo normalnega območja.
Mimpara with food and drink
Zdravilo Mimpara skupaj s hrano in pijačo
Min, Max
min., maks.
mind that the twice weekly dosage
na teden izpostavljenost rifabutinu
Mineral hydrocarbons, low to high viscosity including microcristalline waxes, approximately C10-C60; aliphatic, branched aliphatic and alicyclic compounds.
Mineralni ogljikovodiki, majhne do velike viskoznosti: mikrokristalni voski, približno C10–C60; alifatske, razvejane alifatske in aliciklične spojine
Mineral metabolism
Presnova mineralov
Mineral oil
Mineralno olje
Mineral oil (Marcol 52) 425 l,
Mineralno olje (Marcol 52) 425 μl